Cargando…

Biomarkers for Optimization and Personalization of Anti-TNFs in Pediatric Inflammatory Bowel Disease

The use of biological drugs has improved outcomes in pediatric inflammatory bowel disease (IBD). Prediction of the response to biological drugs would be extremely useful in IBD, and even more so in children, who are still growing physically and psychologically. Specific clinical, biochemical, and ge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salvador-Martín, Sara, Melgarejo-Ortuño, Alejandra, López-Fernández, Luis A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617733/ https://www.ncbi.nlm.nih.gov/pubmed/34834201 http://dx.doi.org/10.3390/pharmaceutics13111786

Ejemplares similares

Association between Genetic Polymorphisms and Response to Anti-TNFs in Patients with Inflammatory Bowel Disease
por: Prieto-Pérez, Rocío, et al.
Publicado: (2016)

Serum Bile Acids Profiling in Inflammatory Bowel Disease Patients Treated with Anti-TNFs
por: Roda, Giulia, et al.
Publicado: (2019)

Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management
por: Roda, Giulia, et al.
Publicado: (2016)

Use of anti-TNFs for difficult-to-treat urticaria: response to Cooke et al
por: Thomsen, Simon Francis, et al.
Publicado: (2015)

When rheumatology meets hepatology: are anti-TNFs safe in hepatitis B virus carriers?
por: Jansen, Tim L
Publicado: (2010)

Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active disease
por: Taylor, Peter C., et al.
Publicado: (2023)

PReS-FINAL-2250: Presentation of tuberculosis in patients using anti-TNFS drugs: report of 3 cases
por: Bica, BE, et al.
Publicado: (2013)

Certolizumab pegol has a different profile from other anti-TNFs, including golimumab, in a variety of in vitro assays
por: Fossati, G, et al.
Publicado: (2010)

Gene Signatures of Early Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease
por: Salvador-Martín, Sara, et al.
Publicado: (2020)

Whole Transcription Profile of Responders to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease
por: Salvador-Martín, Sara, et al.
Publicado: (2021)

Use of non-TNF biologics for the treatment of neuro-Behçet's disease: Literature review and 2 refractory cases of monoclonal anti-TNFs treated with tocilizumab
por: Karabulut, Yusuf
Publicado: (2022)

Real-world outcomes associated with switching to anti-TNFs versus other biologics in Crohn’s Disease patients: A retrospective analysis using German claims data
por: Zhuleku, Evi, et al.
Publicado: (2022)

Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort
por: Salvador-Martín, Sara, et al.
Publicado: (2023)

Pancreatic Involvement in Pediatric Inflammatory Bowel Disease
por: Martín-de-Carpi, Javier, et al.
Publicado: (2017)

Relationship of clinical symptoms with biomarkers of inflammation in pediatric inflammatory bowel disease
por: Hoekman, Daniël R., et al.
Publicado: (2016)

Nailfold Capillaroscopy as a Biomarker in the Evaluation of Pediatric Inflammatory Bowel Disease
por: Kurowski, Jacob A, et al.
Publicado: (2021)

Biomarker discovery for personalized therapy selection in inflammatory bowel diseases: Challenges and promises
por: Alsoud, Dahham, et al.
Publicado: (2022)

Transition from pediatric to adult medical care – A survey in young persons with inflammatory bowel disease
por: Timmer, Antje, et al.
Publicado: (2017)

Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease
por: Duvoisin, Gilles, et al.
Publicado: (2017)

Biomarkers of Inflammatory Bowel Disease
por: Fengming, Yi, et al.
Publicado: (2014)

Personalized Nutrition for Inflammatory Bowel Disease
por: Collins, Colm B, et al.
Publicado: (2020)

Editorial: Pediatric Inflammatory Bowel Diseases: Looking to the Future
por: Wine, Eytan, et al.
Publicado: (2020)

Quality Improvement Methodology Optimizes Infliximab Levels in Pediatric Patients with Inflammatory Bowel Disease
por: Hellmann, Jennifer, et al.
Publicado: (2021)

Recent Advances in the Optimization of Anti-TNF Treatment in Patients with Inflammatory Bowel Disease
por: Orfanoudaki, Eleni, et al.
Publicado: (2023)

Ultrasonography in pediatric inflammatory bowel diseases
por: Massimetti, Mauro, et al.
Publicado: (2014)

Adalimumab in Pediatric Inflammatory Bowel Disease
por: Choi, So Yoon, et al.
Publicado: (2022)

Biomarkers in management of inflammatory bowel disease
por: Moniuszko, Andrzej, et al.
Publicado: (2013)

Serum Biomarkers for Inflammatory Bowel Disease
por: Chen, Peng, et al.
Publicado: (2020)

Inflammatory Bowel Disease: A Personalized Approach
por: Konidari, Anastasia, et al.
Publicado: (2021)

Serum miRNAs Are Pharmacodynamic Biomarkers Associated With Therapeutic Response in Pediatric Inflammatory Bowel Disease
por: Batra, Suruchi K, et al.
Publicado: (2020)

Serum cytokines MCP-1 and GCS-F as potential biomarkers in pediatric inflammatory bowel disease
por: Ott, Andrea, et al.
Publicado: (2023)

Dysbiosis in the Pathogenesis of Pediatric Inflammatory Bowel Diseases
por: Comito, Donatella, et al.
Publicado: (2012)

Nutritional concerns in pediatric inflammatory bowel disease
por: Kim, Yong Joo
Publicado: (2016)

Dermatological Manifestations in Pediatric Inflammatory Bowel Disease
por: Diaconescu, Smaranda, et al.
Publicado: (2020)

Diet and Nutrition in Pediatric Inflammatory Bowel Diseases
por: Cucinotta, Ugo, et al.
Publicado: (2021)

Controlling Gut Inflammation by Restoring Anti-Inflammatory Pathways in Inflammatory Bowel Disease
por: Giuffrida, Paolo, et al.
Publicado: (2019)

Spatial cluster mapping and environmental modeling in pediatric inflammatory bowel disease
por: Michaux, Mielle, et al.
Publicado: (2023)

Characteristics of Fecal Microbiota and Machine Learning Strategy for Fecal Invasive Biomarkers in Pediatric Inflammatory Bowel Disease
por: Wang, Xinqiong, et al.
Publicado: (2021)

Are Probiotics or Prebiotics Useful in Pediatric Irritable Bowel Syndrome or Inflammatory Bowel Disease?
por: Guandalini, Stefano
Publicado: (2014)

Positioning and Usefulness of Biomarkers in Inflammatory Bowel Disease
por: Sakurai, Toshiyuki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c6jeeukojktvm00fnr9rt4icdf